Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 26 2015

Print

Breaking News

October 1, 2013
Rexroad, Session, and Barth take on HR, corporate and clinical development roles  Read More »
October 1, 2013
To combine TrackWise and QualityDocs  Read More »
October 1, 2013
Expands biologics CMO business Laureate  Read More »
October 1, 2013
Tammara, Hu to lead expansion efforts in regulatory affairs and drug development  Read More »
October 1, 2013
Tavakkol to lead regulatory affairs and scientific services  Read More »
October 1, 2013
Aims to improve marketing to international healthcare companies  Read More »
September 30, 2013
Will supply product for Phase I trials  Read More »
September 30, 2013
Expands nanoscale solutions  Read More »
September 30, 2013
Oncology molecule moves to Phase I trials  Read More »
September 30, 2013
Pfizer gains rights to GL-2045 drug candidate  Read More »
September 30, 2013
To divest Arixtra and Fraxiparine brands for $1.1 billion  Read More »
September 30, 2013
Stankovic, Newman take on newly created roles  Read More »
September 30, 2013
Will manufacture transdermal patch for EU product launch  Read More »
Gil Roth
September 30, 2013
AcelRx, Alnylam, Astellas, Cardiome, DiaMedica, Halozyme, Immunomedics, Lion Biotech, Omeros, Tesaro, USB, Vertex  Read More »
Gil Roth
September 27, 2013
CSL Behring, Durata, Novartis, Zalicus  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On